Bill continues Senate’s work to lower prescription drug costs, promote transparency, and increase patient access
BOSTON (11/15/2023) — Today, the Massachusetts Senate unanimously passed the bipartisan Act Relative to Pharmaceutical Access, Costs, and Transparency, otherwise known as the PACT Act 3.0. The legislation would make urgent and much-needed reforms to the pharmaceutical system in the state by lowering the cost of drugs at the pharmacy counter and improving oversight of the pharmaceutical industry.
It also takes firm steps to create more equitable access to life-saving medications by providing a free, no-cost sharing option for certain drugs used to treat chronic illnesses that disproportionately affect people of color.
“Relief from prescription drug costs can’t wait when lives are at stake,” said Senate President Karen E. Spilka (D-Ashland). “I look forward to this bill getting signed into law so that residents and seniors who go to the pharmacy counter will finally pay less for the medications they use to stay alive and maintain their quality of life. This reform is in line with the Senate’s commitment to addressing affordability, equity, and transparency, and maintaining the Commonwealth’s competitiveness as a place to live and work. I am extremely grateful for the diligent and tireless work of Senator Friedman and Chair Rodrigues for their leadership on this bill, and to the rest of my colleagues in the Senate for their strong support.”
“I am pleased the Senate has passed this crucial prescription drug legislation,” said Senator Michael J. Rodrigues (D-Westport), Chair of the Senate Committee on Ways and Means.… Read more.